Esophageal Squamous Cell Carcinoma
Oncology·MeSH: Esophageal Squamous Cell Carcinoma
9 drugs in development·7 companies·15 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| Serplulimab | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| cetuximab | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Esophageal Squamous Cell Carcinoma?
BioSniper tracks 9 drugs in development for Esophageal Squamous Cell Carcinoma across 7 companies.
How many clinical trials target Esophageal Squamous Cell Carcinoma?
There are 15 clinical trials targeting Esophageal Squamous Cell Carcinoma tracked by BioSniper.
Deep-dive into Esophageal Squamous Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis